MIOSTAT Side Effects

6646698-9 | Corneal Oedema, Product Deposit, Visual Acuity Reduced
on Mar 02, 2010 Male patient from UNITED STATES , weighting 169.8 lb, was diagnosed with cataract operation and was treated with Miostat (View Usage). Patient experienced the following unwanted or unexpected effects: corneal oedema, product deposit, visual acuity reduced. Miostat dosage: Intraocular. During the same period patient was treated with VISCOAT (View Viscoat Review and Viscoat Label ), PROVISC (View Provisc Review and Provisc Label ), FLOMAX (FLOMAX) (View Flomax (flomax) Review and Flomax (flomax) Label ).

6318455-4 | Post Procedural Complication, Visual Impairment
Patient was taking Miostat (View Usage). Patient had the following side effects: post procedural complication, visual impairment on Aug 07, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 219.0 lb, was diagnosed with cataract operation and. Miostat dosage: 1.5 Ml Intraocular. During the same period patient was treated with DUOVISC (View Duovisc Review and Duovisc Label ).

6094297-2 | Iris Haemorrhage
Adverse event was reported on Feb 10, 2009 by a Female patient taking Miostat (View Usage) (Dosage: Intraocular) . Location: KOREA, REPUBLIC OF , 71 years of age, After Miostat was administered, patient had the following side effects: iris haemorrhage.

6094134-6 | Iris Haemorrhage, Product Quality Issue
on Feb 10, 2009 Female patient from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF , 66 years of age, was treated with Miostat (View Usage). Patient experienced the following unwanted or unexpected effects: iris haemorrhage, product quality issue. Miostat dosage: Intraocular. During the same period patient was treated with GATIFLOXACIN (View Gatifloxacin Review and Gatifloxacin Label ).


5893342-4 | Inflammation, Post Procedural Complication
on Sep 22, 2008 Female patient from UNITED STATES , 83 years of age, weighting 162.0 lb, was diagnosed with miosis and was treated with Miostat (View Usage). Patient had the following side effects: inflammation, post procedural complication. Miostat dosage: 0.5 Ml Once Intraocular.

5027369-1 | Endophthalmitis
Patient was taking Miostat (View Usage). After Miostat was administered, patient had the following side effects: endophthalmitis on May 25, 2006 from UNITED STATES Additional patient health information: Female patient , 89 years of age, . Miostat dosage: .

5027089-3 | Endophthalmitis
Adverse event was reported on May 25, 2006 by a Female patient taking Miostat (View Usage) (Dosage: ) . Location: UNITED STATES , 76 years of age, Patient experienced the following unwanted or unexpected effects: endophthalmitis.

5027083-2 | Endophthalmitis
on May 25, 2006 Female patient from UNITED STATES , 79 years of age, was treated with Miostat (View Usage). Patient had the following side effects: endophthalmitis. Miostat dosage: .

5026979-5 | Endophthalmitis
on May 25, 2006 Female patient from UNITED STATES , 78 years of age, was treated with Miostat (View Usage). After Miostat was administered, patient had the following side effects: endophthalmitis. Miostat dosage: .

5026977-1 | Endophthalmitis
Patient was taking Miostat (View Usage). Patient experienced the following unwanted or unexpected effects: endophthalmitis on May 25, 2006 from UNITED STATES Additional patient health information: Female patient , 77 years of age, . Miostat dosage: .

5026973-4 | Endophthalmitis, Vitrectomy
Adverse event was reported on May 25, 2006 by a Female patient taking Miostat (View Usage) (Dosage: ) . Location: UNITED STATES , 59 years of age, Patient had the following side effects: endophthalmitis, vitrectomy.

4989483-6 | Anterior Chamber Fibrin, Corneal Oedema, Eye Inflammation, Post Procedural Complication
on Apr 10, 2006 Male patient from UNITED STATES , 79 years of age, was diagnosed with miosis, procedural complication and was treated with Miostat (View Usage). After Miostat was administered, patient had the following side effects: anterior chamber fibrin, corneal oedema, eye inflammation, post procedural complication. Miostat dosage: . During the same period patient was treated with FELODIPINE (View Felodipine Review and Felodipine Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

4962947-7 | Cataract Operation Complication, Glare, Halo Vision, Miosis, Mydriasis, Post Procedural Complication, Syncope
on Mar 14, 2006 Male patient from GERMANY , 78 years of age, was diagnosed with miosis and was treated with Miostat (View Usage). Patient experienced the following unwanted or unexpected effects: cataract operation complication, glare, halo vision, miosis, mydriasis, post procedural complication, syncope. Miostat dosage: Io. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ).

4950462-6 | Cataract Operation Complication, Glare, Halo Vision, Mydriasis
Patient was taking Miostat (View Usage). Patient had the following side effects: cataract operation complication, glare, halo vision, mydriasis on Mar 01, 2006 from GERMANY Additional patient health information: Male patient , 65 years of age, was diagnosed with miosis and. Miostat dosage: 1.5 Ml Once Io.

4950461-4 | Cataract Operation Complication, Glare, Halo Vision, Mydriasis, Syncope
Adverse event was reported on Mar 01, 2006 by a Male patient taking Miostat (View Usage) (Dosage: Io) was diagnosed with miosis and. Location: GERMANY , 78 years of age, After Miostat was administered, patient had the following side effects: cataract operation complication, glare, halo vision, mydriasis, syncope. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ). Patient was hospitalized and became disabled.